Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 18/20 | 0.38 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29678534 | 0.93 | ENPEP (0.39) | ENPEPNOD1RXFP1 | |
| Aminothiazole SCHEMBL19412172 | 0.89 | HSPA5 (0.36) | RXFP1 | |
| SCHEMBL30197694 | 0.89 | NOD1 (0.40) | NOD1 | |
| SCHEMBL29678516 | 0.87 | NPY4R (0.43) | ENPEPNOD1RXFP1 | |
| SCHEMBL29678580 | 0.87 | TERT (0.42) | NOD1 | |
| SCHEMBL29678213 | 0.86 | ENPEP (0.42) | ENPEP | |
| SCHEMBL13723341 | 0.86 | OPRM1 (0.45) | RXFP1 | |
| SCHEMBL30658148 | 0.85 | ENPEP (0.42) | ENPEP | |
| SCHEMBL29784964 | 0.85 | NPY4R (0.39) | RXFP1 | |
| SCHEMBL31318675 | 0.84 | ENPEP (0.47) | ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-06-07 | — | — | US | claimed |
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | F2RL1, F2R, F2RL3 | ENPEP 123/4885NOD1 457/4885RXFP1 244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.